세계 니코틴아미드 모노뉴클레오티드(NMN) 시장(2024년)

The global Nicotinamide Mononucleotide (NMN) market is estimate value at US$ 360.37 million in 2023 and is anticipated to reach US$ 762.61 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.

North American market for Nicotinamide Mononucleotide (NMN) is estimated to increase from $ 59.88 million in 2023 to reach $ 120.04 million by 2030, at a CAGR of 9.73% during the forecast period of 2024 through 2030.

China market for Nicotinamide Mononucleotide (NMN) is estimated to increase from $ 231.27 million in 2023 to reach $ 504.37 million by 2030, at a CAGR of 11.47 % during the forecast period of 2024 through 2030.

The major global manufacturers of Nicotinamide Mononucleotide (NMN) include: GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, and Kingdomway, etc. in 2023, the world's top three vendors accounted for approximately 74.43% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN).

The Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• GeneHarbor
• Herbalmax
• Genex Formulas
• Mirailab Bioscience
• Maac10 Formulas
• EffePharm
• Bontac
• CELFULL
• Kingdomway

Segment by Type

• Content ≥98%
• Content <98%

Segment by Application

• Health Care Products
• Cosmetics
• Others

Production by Region

• North America
• China
• Japan

Consumption by Region

• North America
  • USA
  • Canada

• Asia-Pacific
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India

• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe

• Latin America, Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Nicotinamide Mononucleotide (NMN) Market Overview

• 1.1 Product Definition
• 1.2 Nicotinamide Mononucleotide (NMN) by Type
• 1.3 Nicotinamide Mononucleotide (NMN) by Application
  • 1.3.1 Global Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Application: 2023 VS 2030
  • 1.3.2 Health Care Products
  • 1.3.3 Cosmetics
  • 1.3.4 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)
  • 1.4.2 Global Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2019-2030)
  • 1.4.3 Global Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2019-2030)
  • 1.4.4 Global Nicotinamide Mononucleotide (NMN) Market Average Price Estimates and Forecasts (2019-2030)
• 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

• 2.1 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2019-2024)
• 2.2 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2019-2024)
• 2.3 Global Key Players of Nicotinamide Mononucleotide (NMN), Industry Ranking in 2023
• 2.4 Global Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.5 Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2019-2024)
• 2.6 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Manufacturing Base Distribution and Headquarters
• 2.7 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Date of Established
• 2.8 Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
  • 2.8.1 Nicotinamide Mononucleotide (NMN) Market Concentration Rate
  • 2.8.2 Global 3 and 5 Largest Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
• 2.9 Mergers & Acquisitions, Expansion

3 Nicotinamide Mononucleotide (NMN) Production by Region

• 3.1 Global Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
• 3.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2019-2030)
  • 3.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2019-2024)
  • 3.2.2 Global Forecasted Production Value of Nicotinamide Mononucleotide (NMN) by Region (2025-2030)
• 3.3 Global Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
• 3.4 Global Nicotinamide Mononucleotide (NMN) Production by Region (2019-2030)
  • 3.4.1 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2019-2024)
  • 3.4.2 Global Forecasted Production of Nicotinamide Mononucleotide (NMN) by Region (2025-2030)
• 3.5 Global Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2019-2024)
• 3.6 Global Nicotinamide Mononucleotide (NMN) Production and Value, Year-over-Year Growth
  • 3.6.1 North America Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)
  • 3.6.2 China Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)
  • 3.6.3 Japan Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)

4 Nicotinamide Mononucleotide (NMN) Consumption by Region

• 4.1 Global Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
• 4.2 Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2019-2030)
  • 4.2.1 Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2019-2030)
  • 4.2.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2025-2030)
• 4.3 North America
  • 4.3.1 North America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
  • 4.3.2 North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2019-2030)
  • 4.3.3 USA
  • 4.3.4 Canada
• 4.4 Europe
  • 4.4.1 Europe Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
  • 4.4.2 Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2019-2030)
  • 4.4.3 Germany
  • 4.4.4 France
  • 4.4.5 U.K.
  • 4.4.6 Italy
  • 4.4.7 Russia
• 4.5 Asia Pacific
  • 4.5.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
  • 4.5.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Region (2019-2030)
  • 4.5.3 China
  • 4.5.4 Japan
  • 4.5.5 Korea
  • 4.5.6 Southeast Asia
  • 4.5.7 India
• 4.6 Latin America, Middle East & Africa

5 Segment by Type

• 5.1 Global Nicotinamide Mononucleotide (NMN) Production by Type (2019-2030)
  • 5.1.1 Global Nicotinamide Mononucleotide (NMN) Production by Type (2019-2024)
  • 5.1.2 Global Nicotinamide Mononucleotide (NMN) Production by Type (2025-2030)
  • 5.1.3 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2019-2030)
• 5.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2019-2030)
  • 5.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2019-2024)
  • 5.2.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2025-2030)
  • 5.2.3 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2019-2030)
• 5.3 Global Nicotinamide Mononucleotide (NMN) Price by Type (2019-2030)

6 Segment by Application

• 6.1 Global Nicotinamide Mononucleotide (NMN) Production by Application (2019-2030)
  • 6.1.1 Global Nicotinamide Mononucleotide (NMN) Production by Application (2019-2024)
  • 6.1.2 Global Nicotinamide Mononucleotide (NMN) Production by Application (2025-2030)
  • 6.1.3 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2019-2030)
• 6.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2019-2030)
  • 6.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2019-2024)
  • 6.2.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2025-2030)
  • 6.2.3 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2019-2030)
• 6.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030)

7 Key Companies Profiled

• 7.1 GeneHarbor
  • 7.1.1 GeneHarbor Nicotinamide Mononucleotide (NMN) Company Information
  • 7.1.2 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.1.4 GeneHarbor Main Business and Markets Served
  • 7.1.5 GeneHarbor Recent Developments/Updates
• 7.2 Herbalmax
  • 7.2.1 Herbalmax Nicotinamide Mononucleotide (NMN) Company Information
  • 7.2.2 Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.2.4 Herbalmax Main Business and Markets Served
• 7.3 Genex Formulas
  • 7.3.1 Genex Formulas Nicotinamide Mononucleotide (NMN) Company Information
  • 7.3.2 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.3.4 Genex Formulas Main Business and Markets Served
• 7.4 Mirailab Bioscience
  • 7.4.1 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Company Information
  • 7.4.2 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.4.4 Mirailab Bioscience Main Business and Markets Served
  • 7.4.5 Mirailab Bioscience Recent Developments/Updates
• 7.5 Maac10 Formulas
  • 7.5.1 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Company Information
  • 7.5.2 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.5.4 Maac10 Formulas Main Business and Markets Served
• 7.6 EffePharm
  • 7.6.1 EffePharm Nicotinamide Mononucleotide (NMN) Company Information
  • 7.6.2 EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.6.4 EffePharm Main Business and Markets Served
• 7.7 Bontac
  • 7.7.1 Bontac Nicotinamide Mononucleotide (NMN) Company Information
  • 7.7.2 Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.7.3 Bontac Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.7.4 Bontac Main Business and Markets Served
  • 7.7.5 Bontac Recent Developments/Updates
• 7.8 CELFULL
  • 7.8.1 CELFULL Nicotinamide Mononucleotide (NMN) Company Information
  • 7.8.2 CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.8.4 CELFULL Main Business and Markets Served
• 7.9 Kingdomway
  • 7.9.1 Kingdomway Nicotinamide Mononucleotide (NMN) Company Information
  • 7.9.2 Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio
  • 7.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
  • 7.9.4 Kingdomway Main Business and Markets Served

8 Industry Chain and Sales Channels Analysis

• 8.1 Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
• 8.2 Nicotinamide Mononucleotide (NMN) Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 Nicotinamide Mononucleotide (NMN) Production Mode & Process
• 8.4 Nicotinamide Mononucleotide (NMN) Sales and Marketing
• 8.5 Nicotinamide Mononucleotide (NMN) Customers

9 Nicotinamide Mononucleotide (NMN) Market Dynamics

• 9.1 Nicotinamide Mononucleotide (NMN) Industry Trends
• 9.2 Nicotinamide Mononucleotide (NMN) Market Drivers
• 9.3 Nicotinamide Mononucleotide (NMN) Market Challenges
• 9.4 Nicotinamide Mononucleotide (NMN) Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

• 11.1 Methodology/Research Approach
  • 11.1.1 Research Programs/Design
  • 11.1.2 Market Size Estimation
  • 11.1.3 Market Breakdown and Data Triangulation
• 11.2 Data Source
  • 11.2.1 Secondary Sources
  • 11.2.2 Primary Sources
• 11.3 Author List
• 11.4 Disclaimer 100